Ovid Therapeutics OVID
NASDAQ OVID
$2.49 -0.05 (-1.97%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) EV to CFO (2021)

Updated

Ovid Therapeutics' (OVID) EV to CFO was 0.32 for Q4 2021, up 39.4% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) EV to CFO (2021) Analysis & Trends

Dating back to Q1 2021, Ovid Therapeutics' EV to CFO record includes 4 quarters.

  • Five-year quarterly EV to CFO spans a low of 0.23 in Q3 2021 and a high of 0.42 in Q2 2021.
  • Per Business Quant data, the three quarters before Q4 2021 came in at 0.23 (Q3 2021), 0.42 (Q2 2021) and 0.31 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ovid Therapeutics 460.04 Mn 92.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.32
Sep 30, 2021 0.23
Jun 30, 2021 0.42
Mar 31, 2021 0.31
API Access

Ovid Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=OVID&period=max&api_key=YOUR_API_KEY